Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse

Journal of Neuroscience

Volumn 23, Issue 23, 2003, Pages 8271-8280

  Gadd, Christopher A ^a   Murtra, Patricia ^a,b   De Felipe, Carmen ^b   Hunt, Stephen P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

Amygdala; Anxiety; Conditioned place preference; Elevated plus maze; Morphine; Neurokinin 1 receptor; Nucleus accumbens; Reward; Substance P; Substance P saporin

Indexed keywords

COCAINE; MORPHINE; NEUROKININ 1 RECEPTOR; NEUROPEPTIDE; NEUROTOXIN; SAPORIN; SUBSTANCE P;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CAUDATE NUCLEUS; CONDITIONING; CONTROL SYSTEM; CONTROLLED STUDY; GENETIC MANIPULATION; KNOCKOUT MOUSE; LOCOMOTION; MAZE TEST; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REWARD;

EID: 0141632938     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-23-08271.2003     Document Type: Article

References (68)

1. Alderson HL, Robbins TW, Everitt BJ (2000) The effects of excitotoxic lesions of the basolateral amygdala on the acquisition of heroin-seeking behaviour in rats. Psychopharmacology 153:111-119.
2. Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31-43.
3. Bechara A, van der Kooy D (1989) The tegmental pedunculopontine nucleus: a brainstem output of the limbic system critical for the conditioned place preferences produced by morphine and amphetamine. J Neurosci 9:3400-3409.
4. Bechara A, van der Kooy D (1992) A single brain stem substrate mediates the motivational effects of both opiates and food in nondeprived rats but not in deprived rats. Behav Neurosci 106:351-363.
5. Ben-Ari Y, Zigmond RE, Moore KE (1975) Regional distribution of tyrosine hydroxylase, norepinephrine and dopamine within the amygdaloid complex of the rat. Brain Res 87:96-101.
6. Block CH, Hoffman G, Kapp BS (1989) Peptide-containing pathways from the parabrachial complex to the central nucleus of the amygdala. Peptides 10:465-471.
7. Boix F, Sandor P, Nogueira PJ, Huston JP, Schwarting RK (1995) Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region. Neuroscience 64:1045-1055.
8. 1 receptor) antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs. Neuropharmacology 41:130-137.
9. Cador M, Robbins TW, Everitt BJ (1989) Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum. Neuroscience 30:77-86.
10. Cantarella PA, Chahl LA (1996) Acute effects of morphine on Substance P concentrations in microdissected regions of guinea-pig brain. Behav Pharmacol 7:470-476.
11. Cassell MD, Gray TS (1989) Morphology of peptide-immunoreactive neurons in the rat central nucleus of the amygdala. J Comp Neurol 281:320-333.
12. Cassell MD, Gray TS, Kiss JZ (1986) Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological, and immunocyto-chemical study. J Comp Neurol 246:478-499.
13. Chen LW, Wei LC, Liu HL, Rao ZR (2000) Noradrenergic neurons expressing substance P receptor (NK1) in the locus coeruleus complex: a double immunofluorescence study in the rat. Brain Res 873:155-159.
14. De Felipe C, Herrero JF, O'Brien JA, Palmer JA, Doyle CA, Smith AJ, Laird JM, Belmonte C, Cervero F, Hunt SP (1998) Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392:394-397.
15. Di Chiara G, Tanda G, Bassareo V, Pontieri F, Acquas E, Fenu S, Cadoni C, Carboni E (1999) Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. Ann NY Acad Sci 877:461-485.
16. Emson PC, Jessell T, Paxinos G, Cuello AC (1978) Substance P in the amygdaloid complex, bed nucleus and stria terminalis of the rat brain. Brain Res 149:97-105.
17. Everitt BJ, Cador M, Robbins TW (1989) Interactions between the amygdala and ventral striatum in stimulus-reward associations: studies using a second-order schedule of sexual reinforcement. Neuroscience 30:63-75.
18. Everitt BJ, Morris KA, O'Brien A, Robbins TW (1991) The basolateral amygdala-ventral striatal system and conditioned place preference: further evidence of limbic-striatal interactions underlying reward-related processes. Neuroscience 42:1-18.
19. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. San Diego: Academic.
20. Fuchs RA, See RE (2002) Basolateral amygdala inactivation abolishes conditioned stimulus- and heroin-induced reinstatement of extinguished heroin-seeking behavior in rats. Psychopharmacology 160:425-433.
21. Fuchs RA, Weber SM, Rice HJ, Neisewander JL (2002) Effects ofexcitotoxic lesions of the basolateral amygdala on cocaine-seeking behavior and cocaine conditioned place preference in rats. Brain Res 929:15-25.
22. Gai WP, Blumbergs PC, Geffen LB, Blessing WW (1993) Galanin-containing fibers innervate substance P-containing neurons in the pedunculopontine tegmental nucleus in humans. Brain Res 618:135-141.
23. Gerfen CR (1991) Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res 556:165-170.
24. Hallanger AE, Wainer BH (1988) Ascending projections from the pedunculopontine tegmental nucleus and the adjacent mesopontine tegmentum in the rat. J Comp Neurol 274:483-515.
25. Halliday GM, Gai WP, Blessing WW, Geffen LB (1990) Substance P-containing neurons in the pontomesencephalic tegmentum of the human brain. Neuroscience 39:81-96.
26. Handley SL, Mithani S (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of "fear"-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol 327:1-5.
27. Hasenöhrl RU, Frisch C, Huston JP (1998) Evidence for anatomical specificity for the reinforcing effects of SP in the nucleus basalis magnocellularis. NeuroReport 9:7-10.
28. Hiroi N, White NM (1991) The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference. J Neurosci 11:2107-2116.
29. Holzhäuer-Oitzl MS, Hasenöhrl R, Huston JP (1988) Reinforcing properties of substance P in the region of the nucleus basalis magnocellularis in rats. Neuropharmacology 27:749-756.
30. Kaneko T, Shigemoto R, Nakanishi S, Mizuno N (1993) Substance P receptor-immunoreactive neurons in the rat neostriatum are segregated into somatostatinergic and cholinergic aspiny neurons. Brain Res 631:297-303.
31. Katona I, Rancz EA, Acsády L, Ledent C, Mackie K, Hájos N, Freund TF (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21:9506-9518.
32. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chic-chi GG, Sadowski S, Williams AR, Hewson L, Smith D, Rupniak NM (1998) Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281:1640-1645.
33. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283:401-404.
34. Malsbury CW, McKay K (1989) Sex difference in the substance P-immunoreactive innervation of the medial nucleus of the amygdala. Brain Res Bull 23:561-567.
35. Mantyh PW, Rogers SD, Honore P, Allen BJ, Ghilardi JR, Li J, Daughters RS, Lappi DA, Wiley RG, Simone DA (1997) Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science 278:275-279.
36. Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O (2000) Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur J Neurosci 12:4038-4046.
37. Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O (2002) Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology 159:379-387.
38. Maubach KA, Martin K, Smith DW, Hewson L, Frankshun RA, Harrison T, Seabrook GR (2001) Substance P stimulates inhibitory synaptic transmission in the guinea pig basolateral amygdala in vitro. Neuropharmacology 40:806-817.
39. McDonald AJ, Mascagni F (2001) Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a sub-population of cholecystokinin-containing interneurons. Neuroscience 107:641-652.
40. McDonald RJ, White NM (1993) A triple dissociation of memory systems: hippocampus, amygdala, and dorsal striatum. Behav Neurosci 107:3-22.
41. Montgomery KC (1955) The relation between fear induced by novel stimulation and exploratory drive, J Comp Physiol Psychol 48:254-260.
42. Moyse E, Marcel D, Leonard K, Beaudet A (1997) Electron microscopic distribution of mu opioid receptors on noradrenergic neurons of the locus coeruleus. Eur J Neurosci 9:128-139.
43. Murtra P, Sheasby AM, Hunt SP, De Felipe C (2000) Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 405:180-183.
44. Nakaya Y, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N (1994) Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J Comp Neurol 347:249-274.
45. Nestler EJ, Alreja M, Aghajanian GK (1994) Molecular and cellular mechanisms of opiate action: studies in the rat locus coeruleus. Brain Res Bull 35:521-528.
46. Nestler EJ, Alreja M, Aghajanian GK (1999) Molecular control oflocus coeruleus neurotransmission. Biol Psychiatry 46:1131-1139.
47. Nichols ML, Allen BJ, Rogers SD, Ghilardi JR, Honore P, Luger NM, Finke MP, Li J, Lappi DA, Simone DA, Mantyh PW (1999) Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 286:1558 -1561.
48. Olmstead MC, Franklin KB (1993) Effects of pedunculopontine tegmental nucleus lesions on morphine-induced conditioned place preference and analgesia in the formalin test. Neuroscience 57:411-418.
49. Parker JL, van der Kooy D (1995) Tegmental pedunculopontine nucleus lesions do not block cocaine reward. Pharmacol Biochem Behav 52:77-83.
50. Parkinson JA, Crofts HS, McGuigan M, Tomic DL, Everitt BJ, Roberts AC (2001) The role of the primate amygdala in conditioned reinforcement. J Neurosci 21:7770-7780.
51. Petrov T, Krukoff TL, Jhamandas JH (1994) Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat. Cell Tissue Res 277:289-295.
52. Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106:274-285.
53. Rezayof A, Zarrindast MR, Sahraei H, Haeri-Rohani AH (2002) Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Pharmacol Biochem Behav 74:187-197.
54. Ricciardi KH, Blaustein JD (1994) Projections from ventrolateral hypothalamic neurons containing progestin receptor- and substance P-immunoreactivity to specific forebrain and midbrain areas in female guinea pigs. J Neuroendocrinol 6:135-144.
55. Ripley TL, Gadd CA, De Felipe C, Hunt SP, Stephens DN (2002) Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors. Neuropharmacology 43:1258-1268.
56. Robbins TW, Everitt BJ (1996) Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol 6:228-236.
57. Roberts GW, Woodhams PL, Polak JM, Crow TJ (1982) Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complex. Neuroscience 7:99-131.
58. 1) receptors attenuates neonatal vocalisation in guinea-pigs and mice. Neuropharmacology 39:1413-1421.
59. Santarelli L, Gobbi G, Debs PC, Sibille EL, Blier P, Hen R, Heath MJ (2001) Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci USA 98:1912-1917.
60. 1 receptor internalisation in the basolateral amygdala. Brain Res 848:90-95.
61. Steinberg R, Alonso R, Rouquier L, Desvignes C, Michaud JC, Cudennec A, Jung M, Simiand J, Griebel G, Emonds-Alt X, Le Fur G, Soubrié P (2002) SSR240600 [(R)-2-(1-[2-[4-[2-[3, 5-bis(trifluoromethyl)phenyl]acetyl]-2-(3, 4-dichloro phenyl)-2-morpholinyl] ethyl] -4-piperidinyl)-2-methyl-propanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin 1 receptor. II. Neurochemical and behavioral characterization. J Pharmacol Exp Ther 303:1180-1188.
62. Truitt WA, Coolen LM (2002) Identification ofa potential ejaculation generator in the spinal cord. Science 297:1566-1569.
63. Ungerstedt U (1971) Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl 367:1-48.
64. Varty GB, Cohen-Williams ME, Morgan CA, Pylak U, Duffy RA, Lachowicz JE, Carey GJ, Coffin VL (2002) The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists. Neuropsychopharmacology 27:371-379.
65. Wallace DM, Magnuson DJ, Gray TS (1992) Organization of amygdaloid projections to brainstem dopaminergic, noradrenergic, and adrenergic cell groups in the rat. Brain Res Bull 28:447-454.
66. Wang H, Germanson TP, Guyenet PG (2002) Depressor and tachypneic responses to chemical stimulation of the ventral respiratory group are reduced by ablation of neurokinin-1 receptor-expressing neurons. J Neurosci 22:3755-3764.
67. Wiley RG, Lappi DA (1997) Destruction of neurokinin-1 receptor expressing cells in vitro and in vivo using substance P-saporin in rats. Neurosci Lett 230:97-100.
68. Yamano M, Hillyard CJ, Girgis S, MacIntyre I, Emson PC, Tohyama M (1988) Presence of a substance P-like immunoreactive neurone system from the parabrachial area to the central amygdaloid nucleus of the rat with reference to coexistence with calcitonin gene-related peptide. Brain Res 451:179-188.